Full-service neuroscience clinical development

We excel at transforming foundational research into impactful clinical outcomes and data. Our team translates preclinical findings into strategic and efficient clinical development across a broad spectrum of neurological conditions. Leveraging the latest imaging technology and innovative measurement tools, combined with our creative approach to study design and participant recruitment, we ensure the collection of meaningful data from rigorous studies.

We bring a wealth of experience in managing diverse endpoints across a broad spectrum of neurological conditions. Our expertise spans from traditional clinical outcomes to cutting-edge biomarkers and patient-reported outcomes, ensuring comprehensive insights into both disease progression and patient quality of life.

The importance of careful assessment management and training in neuroscience trials cannot be overstated. That’s why we built an in-house team of assessment experts to provide seamless and fast assessment support and training that minimizes rater variability and placebo response. Their expertise includes rater training, scale and translation management, endpoint quality management, clinical outcome assessments (COA), and operational management.

Neuroscience studies can be logistically, statistically, and financially challenging when it comes to navigating the various symptoms and molecular targets and demonstrating changes in the pathophysiology of the disease. Our highly flexible, fit-for-purpose clinical pharmacology unit and state-of-the-art bioanalytical laboratory support objective biomarker development, rapid sample processing, and strategic decision-making for early phase research.